Cargando…
Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation
BACKGROUND: The objective of this study was to develop a novel polydatin (PLD)-loaded liposome system using the thin film hydration technique. METHODS: The delivery system was characterized in terms of morphology, size, zeta potential, encapsulation efficiency, and in vitro release. In addition, a p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386770/ https://www.ncbi.nlm.nih.gov/pubmed/25848217 http://dx.doi.org/10.2147/DDDT.S77615 |
_version_ | 1782365204962607104 |
---|---|
author | Wang, Xiaobo Guan, Qigang Chen, Wei Hu, Xianming Li, Li |
author_facet | Wang, Xiaobo Guan, Qigang Chen, Wei Hu, Xianming Li, Li |
author_sort | Wang, Xiaobo |
collection | PubMed |
description | BACKGROUND: The objective of this study was to develop a novel polydatin (PLD)-loaded liposome system using the thin film hydration technique. METHODS: The delivery system was characterized in terms of morphology, size, zeta potential, encapsulation efficiency, and in vitro release. In addition, a pharmacokinetic study was carried out in rats after oral administration of PLD-loaded liposomes in vivo. RESULTS: Transmission electron microscopy revealed that the PLD-loaded liposomes had a homogeneous size and spherical shape. Dynamic light scattering showed that the PLD-loaded liposomes had a smaller size with a mean value of 80.2±3.7 nm and a polydispersity index of 0.12±0.06. The encapsulation efficiency of the prepared liposomes was 88.4%±3.7%. During the release process, liposome showed two distinct phases. The first was characterized by rapid release during the first 2 hours, which could be related to the release of the drug adsorbed on the surface of liposomes. In the second phase, the release rate slowed down, demonstrating a typical sustained and prolonged drug-release behavior. The release kinetic model for the PLD-loaded liposomes fitted well with the Weibull distribution equation. In vivo, relative oral bioavailability of the encapsulated PLD was 282.9%, ie, significantly enhanced (P<0.05) compared with the free drug. No histological changes occurred in the organs after administration of PLD-loaded liposomes. CONCLUSION: PLD-loaded liposomes could significantly prolong the drug circulation time in vivo and increase the oral bioavailability of the drug. |
format | Online Article Text |
id | pubmed-4386770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43867702015-04-06 Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation Wang, Xiaobo Guan, Qigang Chen, Wei Hu, Xianming Li, Li Drug Des Devel Ther Original Research BACKGROUND: The objective of this study was to develop a novel polydatin (PLD)-loaded liposome system using the thin film hydration technique. METHODS: The delivery system was characterized in terms of morphology, size, zeta potential, encapsulation efficiency, and in vitro release. In addition, a pharmacokinetic study was carried out in rats after oral administration of PLD-loaded liposomes in vivo. RESULTS: Transmission electron microscopy revealed that the PLD-loaded liposomes had a homogeneous size and spherical shape. Dynamic light scattering showed that the PLD-loaded liposomes had a smaller size with a mean value of 80.2±3.7 nm and a polydispersity index of 0.12±0.06. The encapsulation efficiency of the prepared liposomes was 88.4%±3.7%. During the release process, liposome showed two distinct phases. The first was characterized by rapid release during the first 2 hours, which could be related to the release of the drug adsorbed on the surface of liposomes. In the second phase, the release rate slowed down, demonstrating a typical sustained and prolonged drug-release behavior. The release kinetic model for the PLD-loaded liposomes fitted well with the Weibull distribution equation. In vivo, relative oral bioavailability of the encapsulated PLD was 282.9%, ie, significantly enhanced (P<0.05) compared with the free drug. No histological changes occurred in the organs after administration of PLD-loaded liposomes. CONCLUSION: PLD-loaded liposomes could significantly prolong the drug circulation time in vivo and increase the oral bioavailability of the drug. Dove Medical Press 2015-03-30 /pmc/articles/PMC4386770/ /pubmed/25848217 http://dx.doi.org/10.2147/DDDT.S77615 Text en © 2015 Wang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Wang, Xiaobo Guan, Qigang Chen, Wei Hu, Xianming Li, Li Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
title | Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
title_full | Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
title_fullStr | Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
title_full_unstemmed | Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
title_short | Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
title_sort | novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386770/ https://www.ncbi.nlm.nih.gov/pubmed/25848217 http://dx.doi.org/10.2147/DDDT.S77615 |
work_keys_str_mv | AT wangxiaobo novelnanoliposomaldeliverysystemforpolydatinpreparationcharacterizationandinvivoevaluation AT guanqigang novelnanoliposomaldeliverysystemforpolydatinpreparationcharacterizationandinvivoevaluation AT chenwei novelnanoliposomaldeliverysystemforpolydatinpreparationcharacterizationandinvivoevaluation AT huxianming novelnanoliposomaldeliverysystemforpolydatinpreparationcharacterizationandinvivoevaluation AT lili novelnanoliposomaldeliverysystemforpolydatinpreparationcharacterizationandinvivoevaluation |